This week 16 organisations met at the Barcelona Supercomputer Centre to mark the start of the EuroEXA project and the next stage of EU investment towards realising exascale computing in Europe
Iceotope, a supplier of liquid cooling technology, has announced the availability of a silent, liquid cooled GPU compatible server blade to accommodate high-performance computing components such as graphics cards and media accelerators.
Iceotope, a British-based sustainable IT cooling provider, has revealed new findings from the University of Leeds and Poznan Supercomputing and Networking Centre (PSNC) outlining significant performance advantages of its cooling technology
UK-based liquid cooling specialist Iceotope has launched what it describes as free cooling for ICT, anywhere at the Cebit trade event in Hanover, Germany
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
